Prevalent premalignancy

Blood. 2017 Aug 10;130(6):695-696. doi: 10.1182/blood-2017-05-786210.

Authors

Adam S Sperling¹, Benjamin L Ebert^{1

2}

Affiliations

¹ DANA-FARBER CANCER INSTITUTE.
² BRIGHAM AND WOMEN'S HOSPITAL.

PMID: 28798057
DOI: 10.1182/blood-2017-05-786210

No abstract available

Publication types

Comment

MeSH terms

Precancerous Conditions*
Prevalence

Grants and funding

T32 HL116324/HL/NHLBI NIH HHS/United States